Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$191.17 - $325.63 $74,747 - $127,321
-391 Reduced 0.52%
74,373 $24.2 Million
Q4 2023

Feb 14, 2024

BUY
$160.99 - $215.69 $1.94 Million - $2.6 Million
12,034 Added 19.18%
74,764 $14.2 Million
Q3 2023

Nov 14, 2023

BUY
$194.33 - $283.97 $3.62 Million - $5.3 Million
18,650 Added 42.31%
62,730 $12.5 Million
Q2 2023

Aug 14, 2023

SELL
$223.05 - $302.68 $339,705 - $460,981
-1,523 Reduced 3.34%
44,080 $12.6 Million
Q1 2023

May 15, 2023

SELL
$175.41 - $217.92 $2.63 Million - $3.27 Million
-14,988 Reduced 24.74%
45,603 $9.89 Million
Q4 2022

Feb 14, 2023

BUY
$204.38 - $296.82 $446,774 - $648,848
2,186 Added 3.74%
60,591 $12.5 Million
Q3 2022

Nov 14, 2022

SELL
$195.21 - $310.53 $7.05 Million - $11.2 Million
-36,122 Reduced 38.21%
58,405 $16.2 Million
Q2 2022

Aug 15, 2022

SELL
$115.91 - $214.48 $5.23 Million - $9.68 Million
-45,113 Reduced 32.31%
94,527 $18.1 Million
Q1 2022

May 13, 2022

SELL
$127.96 - $207.36 $724,893 - $1.17 Million
-5,665 Reduced 3.9%
139,640 $29 Million
Q4 2021

Feb 14, 2022

SELL
$165.13 - $241.83 $1.66 Million - $2.43 Million
-10,055 Reduced 6.47%
145,305 $25.9 Million
Q3 2021

Nov 12, 2021

BUY
$163.99 - $235.57 $426,537 - $612,717
2,601 Added 1.7%
155,360 $32 Million
Q2 2021

Aug 13, 2021

SELL
$131.45 - $201.49 $829,843 - $1.27 Million
-6,313 Reduced 3.97%
152,759 $29 Million
Q1 2021

May 19, 2021

BUY
$92.73 - $142.05 $205,396 - $314,640
2,215 Added 1.41%
159,072 $20.7 Million
Q4 2020

Feb 12, 2021

BUY
$67.44 - $103.72 $215,808 - $331,904
3,200 Added 2.08%
156,857 $16.3 Million
Q3 2020

Nov 13, 2020

BUY
$42.79 - $75.8 $6.3 Million - $11.2 Million
147,331 Added 2328.98%
153,657 $11.6 Million
Q2 2020

Aug 14, 2020

BUY
$27.25 - $47.53 $172,383 - $300,674
6,326 New
6,326 $300,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Bamco Inc Portfolio

Follow Bamco Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.